NCT00499629View on ClinicalTrials.gov

Study Evaluating the Safety of FXR-450 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

FXR 450

capsule, single oral doses from 10 mg to 450 mg

DRUG

placebo

capsule similar to active drug

Trial Locations (1)

19148

Facility, Philadelphia

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00499629 - Study Evaluating the Safety of FXR-450 in Healthy Subjects | Biotech Hunter | Biotech Hunter